Similar articles

• An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.

  Majumdar S, Kirby A, Berry N, Williams C, Hassan I, Eddleston J, Burnie JP. Majumdar S, et al. J Hosp Infect. 2004 Oct;58(2):160-1. doi: 10.1016/j.jhin.2004.06.011. J Hosp Infect. 2004. PMID: 15474190 No abstract available.
• [Incidence and drug sensitivity of Pseudomonas aeruginosa recently isolated in the clinical complex of the Arcispedale di S. Maria Nuova and the Università degli Studi di Firenze].

  Mazzei T, Nicoletti I, Polito P, Masiero G. Mazzei T, et al. G Ital Chemioter. 1975 Jan-Dec;22(1-2):121-8. G Ital Chemioter. 1975. PMID: 828597 Italian. No abstract available.
• Current therapies for pseudomonas aeruginosa.

  Giamarellou H, Kanellakopoulou K. Giamarellou H, et al. Crit Care Clin. 2008 Apr;24(2):261-78, viii. doi: 10.1016/j.ccc.2007.12.004. Crit Care Clin. 2008. PMID: 18361945 Review.
• [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].

  Vanni M, Zucca C. Vanni M, et al. Minerva Med. 1986 Jun 30;77(27):1289-92. Minerva Med. 1986. PMID: 3088493 Italian.
• Optimizing antipseudomonal therapy in critical care.

  Iredell JR. Iredell JR. Semin Respir Crit Care Med. 2007 Dec;28(6):656-61. doi: 10.1055/s-2007-996412. Semin Respir Crit Care Med. 2007. PMID: 18095229 Review.